Regulus Therapeutics Inc. buy HC Wainwright
Start price
25.03.24
/
50%
€2.64
Target price
25.03.25
€8.30
Performance (%)
-14.39%
Price
25.04.24
€2.02
Summary
This prediction is currently active. The prediction for Regulus Therapeutics Inc. disappoints with a performance of -14.39%. This prediction currently runs until 25.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regulus Therapeutics Inc. | 3.061% | 3.061% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
19.09.23
19.09.23
€8.41
19.09.24
19.09.24
34.67%
25.04.24
25.04.24
